The Alzheimer's Enigma: Unraveling the Mystery of APOE2's Protective Power A study from the Buck Institute for Research on Aging has shed light on a long standing enigma in the field of neurodegenerative diseases: the protective effects of the APOE2 gene variant against Alzheimer's disease.
For years, researchers have known that individuals carrying the APOE2 allele tend to live longer and have a lower risk of dementia. However, the underlying biological mechanisms remained unclear.
The latest research has made significant strides in elucidating this phenomenon, revealing that APOE2 plays a critical role in protecting brain cells from DNA damage and cellular senescence.